Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
Articolo
Data di Pubblicazione:
2010
Abstract:
The objective of this study was to assess the effects of subcutaneous (sc) interferon beta-1a (IFNbeta-1a) on cognition in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS). Patients aged 18-50 years with RRMS (McDonald criteria; Expanded Disability Status Scale score
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adolescent, Adult, Cognition Disorders; drug therapy/etiology/psychology, Cohort Studies, Disability Evaluation, Disease Progression, Dose-Response Relationship; Drug, Endpoint Determination, Female, Humans, Immunologic Factors; therapeutic use, Injections; Subcutaneous, Interferon-beta; administration /&/ dosage/therapeutic use, Kaplan-Meier Estimate, Male, Middle Aged, Multiple Sclerosis; Relapsing-Remitting; complications/drug therapy/psychology, Neuropsychological Tests, Prospective Studies, Survival Analysis, Young Adult; multiple sclerosis
Elenco autori:
F., Patti; M. P., Amato; Bastianello, Stefano; L., Caniatti; E. D., Monte; P., Ferrazza; B., Goretti; P., Gallo; V. B., Morra; S. L., Fermo; O., Picconi; M. R., Tola; M., Trojano; C. O., G.
Link alla scheda completa:
Pubblicato in: